Nutrivida
This article was originally published in The Tan Sheet
Executive Summary
FTC bars firm from making any representation that its Cartilet shark cartilage capsules are effective in the relief, treatment or cure of cancer, rheumatism, arthritis, diabetes, fibroids, bursitis, circulatory problems or cysts unless the firm possesses supporting evidence in a Sept. 16 decision and order. FTC announced a proposed settlement with the firm June 26 ("The Tan Sheet" July 6, p. 1)
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning